Cargando…
Clinical Trials and Treatment of ATL
ATL is a distinct peripheral T-lymphocytic malignancy associated with human T-cell lymphotropic virus type I (HTLV-1). The diversity in clinical features and prognosis of patients with this disease has led to its subtype-classification into four categories, acute, lymphoma, chronic, and smoldering t...
Autores principales: | Tsukasaki, Kunihiro, Tobinai, Kensei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505932/ https://www.ncbi.nlm.nih.gov/pubmed/23259064 http://dx.doi.org/10.1155/2012/101754 |
Ejemplares similares
-
Promising results of an anti-CCR4 antibody, KW-0761, for relapsed Adult T-Cell Leukemia-Lymphoma (ATL)
por: Utsunomiya, Atae, et al.
Publicado: (2011) -
ATL internals: working with ATL 8
por: Tavares, Chris
Publicado: (2006) -
Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma
por: Makita, Shinichi, et al.
Publicado: (2020) -
ATL internals /
por: Rector, Brent
Publicado: (1999) -
ATL internals
por: Rector, Brent, et al.
Publicado: (1999)